1.Measurement and clinical significance of serum LDH,MCP-1,and TCF4 in patients with cerebral small vessel disease complicated by depression
Journal of Apoplexy and Nervous Diseases 2026;43(1):47-51
Objective To explore the changes in serum lactate dehydrogenase (LDH), monocyte chemoattractant protein-1 (MCP-1), and transcription factor 4 (TCF4) levels in patients with cerebral small vessel disease complicated by depression and their clinical significance. Methods According to the inclusion and exclusion criteria, 90 patients admitted to the Kailuan General Hospital between January 2022 and August 2024 were selected as the study subjects, including 27 patients diagnosed with cerebral small vessel disease complicated by depression and 63 patients with cerebral small vessel disease uncomplicated by depression. An additional 45 healthy individuals with normal head MRI findings and no mental disorders during the same period at the hospital were selected as the control group. General information was collected from the three groups, including age, body mass index, systolic blood pressure, and diastolic blood pressure.The general information and the levels of serum LDH,MCP-1,and TCF4 in the three groups were compared. The correlations of serum LDH,MCP-1,and TCF4 levels with HAMD score in patients with cerebral small vessel disease and depression were analyzed. Logistic regression was applied to analyze possible factors leading to depression in patients with cerebral small vessel disease.The receiver operating characteristic curve was applied to analyze the efficacy of serum LDH, MCP-1, and TCF4 levels in diagnosing depression in patients with cerebral small vessel disease. Results The levels of serum LDH, MCP-1,and TCF4 were significantly higher in the cerebral small vessel disease complicated by depression group than in cerebral small vessel disease uncomplicated with depression group and the control group (P<0.05), and these levels were significantly higher in the cerebral small vessel disease uncomplicated with depression group than in the control group (P<0.05).The serum LDH,MCP-1 and TCF4 were positively correlated with HAMD score in patients with cerebral small vessel disease complicated with depression(r=0.606,0.798,0.672,all P<0.001).Serum LDH, MCP-1, and TCF4 were influencing factors for depression in cerebral small vessel disease(P<0.05).The area under the receiver operating characteristic curve of LDH, MCP-1,and TCF4 in combination in the diagnosis of depression in cerebral small vessel disease was 0.917, which was superior to serum LDH, MCP-1, and TCF4 alone (ZLDH-combination=2.457,P=0.014;ZMCP-1-combination=2.384, P=0.017; ZTCF4-combination=2.317, P=0.021). Conclusion Serum LDH, MCP-1, and TCF4 levels increased in patients with cerebral small vessel disease complicated with depression. Their combination is valuable in the diagnosis of cerebral small vessel disease complicated with depression.
Depression
2.The development trajectory of sleep disturbance in patients with hepatolenticular degeneration and its relationship with depression:A cross-lagged regression analysis
Journal of Apoplexy and Nervous Diseases 2026;43(2):131-134
Objective To investigate the changing trend of sleep disturbance in patients with hepatolenticular degeneration and the bidirectional relationship between sleep disturbance and depression through a cross-lagged regression analysis. Methods A total of 80 patients who met the diagnostic criteria for WD from January to June 2024 were enrolled in this longitudinal study and were followed up for 3 months.Pittsburgh Sleep Quality Index (PSQI) was used to assess sleep quality, and Beck Depression Inventory (BDI) was used to assess the severity of depression, at the time of enrollment (T0), at 1 month after enrollment (T1),and at 2 months after enrollment (T3). An unconditional growth model was used to analyze the trajectory of sleep disturbance, and a cross-lagged regression model was used to investigate the temporal relationship between sleep disturbance and depression. Results From T0 to T2, there were significant increases in PSQI and BDI scores in all WD patients(P<0.05). The variance of the intercept factor (the initial status of sleep disturbance) was estimated at 10.83(P<0.01),and the variance of the slope factor (the rate of change in sleep disturbance) was 1.20 (P<0.01),with a significant negative correlation between the intercept and the slope (r=-0.25,P<0.01). The correlation analysis of PSQI and BDI scores across the three time points revealed a positive correlation between PSQI and BDI scores (r∈[0.19,0.96],P<0.01).The cross-lagged model analysis showed that sleep disturbance significantly predicted subsequent depression (P<0.01),with standardized regression coefficients (β) of 0.392 and 0.347, respectively; meanwhile, depression also significantly predicted subsequent sleep disturbance (P<0.01), with β of 0.273 and 0.372, respectively. These findings suggested a bidirectional predictive relationship between sleep disturbance and depression in WD patients over time. Conclusion There is a bidirectional relationship between sleep disturbance and depression in patients with WD, and depression has a more pronounced influence on sleep disturbance. Therefore, clinical interventions should focus on both sleep and psychological state, and combined management should be performed to improve the effect of disease control.
Depression
3.Causal relationship between Parkinson disease and the risk of mental illness: A two-sample Mendelian randomization study
Journal of Apoplexy and Nervous Diseases 2026;43(2):145-149
Objective Observational studies have shown an association between Parkinson disease (PD) and mental illness, but further studies are needed to explore the causal relationship between them. This study aims to investigate such causal relationship using the method of two-sample Mendelian randomization (MR). Methods Related data were extracted from GWAS, and summary statistics associated with PD, depression, sleep disorders, and anxiety phenotype-variants were obtained. Single nucleotide polymorphisms (SNPs) for PD were selected as instrumental variables, and MR-PRESSO was used to exclude outliers. Inverse variance weighting was used as the main method to assess causal effect estimates, and MR Egger, weighted median, simple mode, and weighted mode were used to verify the robustness of the findings. A sensitivity analysis was used to validate the reliability of the results, including the Cochran Q test, the MR-Egger intercept test, funnel plots, and the leave-one-out method. Results A total of 21 SNPs associated with PD were identified. The MR analysis showed that PD had a causal relationship with depression (OR=0.974,95%CI 0.934‒1.015, P=0.210), sleep disorders (OR=1.056, 95%CI 0.970-1.149, P=0.211), and anxiety (OR=0.998, 95%CI 0.996‒1.001, P=0.118), with no statistical significance. Different MR analyses and sensitivity analyses showed that PD did not directly contribute to the development of mental illness. Conclusion There is no direct causal relationship between PD and depression/sleep disorders/anxiety. In clinical practice, healthcare professionals should pay attention to the mental health of patients with PD. Randomized controlled studies should be conducted in the future to further validate the results of this study.
Depression
;
Anxiety
4.Climate anxiety and depressive symptoms among undergraduate students of a college in a higher education institution in Manila, Philippines.
Kent Tristan L. ESTEBAN ; Paolo Miguel L. CHAVES ; Venus Maria B. MILAN ; Erylla Beatrish M. OAMIL ; Patricia B. OCAMPO ; Crystal Amiel M. ESTRADA ; Ernesto R. GREGORIO JR.
Acta Medica Philippina 2025;59(18):99-106
BACKGROUND AND OBJECTIVES
Climate anxiety is an emerging concept defined as increased anxiety about climate change and has been linked to negative mental health outcomes. As a relatively new concept, only a few have characterized it and its relationship with mental health, especially in the Global South populations. This study aimed to investigate the relationship between climate anxiety and depressive symptoms among undergraduate students from a college in a higher education institution in Manila, Philippines. Specifically, it aimed to (1) determine the proportion of undergraduate students who reported high levels of climate anxiety and depressive symptoms; and (2) determine the association between climate anxiety and depressive symptoms.
METHODSUsing a cross-sectional design and a convenience sampling method, the investigators collected data through an online survey to assess levels of climate anxiety and depressive symptoms using the Climate Change Anxiety Scale (CCAS) and the Patient Health Questionnaire 9 (PHQ-9), respectively. Data was analyzed using multiple logistic regression.
RESULTSAmong the 148 respondents (N=325), 14.86% had high climate anxiety (i.e., CCAS score >= 3) and 62.84% had high depressive symptoms (i.e., PHQ-9 score >= 10). Regression analysis showed that the odds of those having high climate anxiety reporting high depressive symptoms are higher than those with low climate anxiety, though this is not significant (OR = 2.53, p=0.144).
CONCLUSIONThe study verifies the existence of climate anxiety among undergraduate students and reflects an alarming mental health situation in the selected college. It is recommended that wide-scope investigations on the current state of climate anxiety and mental health among the youth be done to verify their impacts, along with inter-sectoral efforts such as increasing awareness through health education interventions to improve the youths’ mental health literacy and resilience to the effects of climate change, and promoting climate change-responsive mental health services to address these as pressing threats to youth health.
Human ; Climate Anxiety ; Depressive Symptoms ; Depression ; Mental Health
5.Risk and protective factors associated with adolescent depression in Singapore: a systematic review.
Wei Sheng GOH ; Jun Hao Norman TAN ; Yang LUO ; Sok Hui NG ; Mohamed Sufyan Bin Mohamed SULAIMAN ; John Chee Meng WONG ; Victor Weng Keong LOH
Singapore medical journal 2025;66(1):2-14
INTRODUCTION:
Adolescent depression is prevalent, and teen suicide rates are on the rise locally. A systemic review to understand associated risk and protective factors is important to strengthen measures for the prevention and early detection of adolescent depression and suicide in Singapore. This systematic review aims to identify the factors associated with adolescent depression in Singapore.
METHODS:
A systematic search on the following databases was performed on 21 May 2020: PubMed, EMBASE and PsycINFO. Full texts were reviewed for eligibility, and the included studies were appraised for quality using the Newcastle Ottawa Scale. Narrative synthesis of the finalised articles was performed through thematic analysis.
RESULTS:
In total, eight studies were included in this review. The four factors associated with adolescent depression identified were: (1) sociodemographic factors (gender, ethnicity); (2) psychological factors, including childhood maltreatment exposure and psychological constructs (hope, optimism); (3) coexisting chronic medical conditions (asthma); and (4) lifestyle factors (sleep inadequacy, excessive internet use and pathological gaming).
CONCLUSION
The identified factors were largely similar to those reported in the global literature, except for sleep inadequacy along with conspicuously absent factors such as academic stress and strict parenting, which should prompt further research in these areas. Further research should focus on current and prospective interventions to improve mental health literacy, targeting sleep duration, internet use and gaming, and mitigating the risk of depression in patients with chronic disease in the primary care and community setting.
Humans
;
Singapore/epidemiology*
;
Adolescent
;
Risk Factors
;
Depression/etiology*
;
Protective Factors
;
Male
;
Female
;
Life Style
;
Suicide
6.Anxiety in hospitalised families: lessons from the early phase of the COVID-19 pandemic.
Annushkha SINNATHAMBY ; Siau Hwei NG ; Amanda ZAIN ; Liangjian LU ; Celeste YONG ; Xinyi THONG ; Si Min CHAN
Singapore medical journal 2025;66(6):327-332
INTRODUCTION:
In the early phase of the coronavirus disease 2019 (COVID-19) pandemic, children with COVID-19 in Singapore required hospital isolation. We aimed to explore the psychological experiences of children and their caregivers isolated in a tertiary university hospital due to COVID-19.
METHODS:
A prospective mixed-methods design was used to evaluate the psychological status of hospitalised family units with one or more children aged <18 years who had severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Patient medical records were reviewed for demographic and clinical information. Parents and children ≥7 years of age underwent a psychologist-administered telephone-based interview. Self-reported, age-appropriate instruments, Short Mood and Feelings Questionnaire, and Screen for Adult/Child Anxiety-Related Disorders, were used to assess anxiety and depression, respectively. Participants were also interviewed qualitatively.
RESULTS:
Fifteen family units were hospitalised between March 2020 and May 2020. Of these, 13 (73%) family units were recruited. The median age of the children and median hospitalisation duration were 57 months and 21 days, respectively. Median number of COVID-19 polymerase chain reaction swabs performed for each child was eight. All children had asymptomatic to mild SARS-CoV-2 disease. The criteria indicative of anxiety disorder were met by 40% of adults and 80% of children, while the criteria indicative of separation anxiety were met by 60% of parents and 100% of children. One child met the criteria indicative of depression. Uncertainty, separation, prolonged hospitalisation and frequent swabs caused significant reported anxiety.
CONCLUSIONS
Families, especially children, had heightened anxiety while in hospital isolation. Therefore, home-based recovery from COVID-19 and psychological support for children and their families, with focus on early recognition of anxiety disorders, are recommended. We support review of paediatric isolation policy as the pandemic evolves.
Humans
;
COVID-19/epidemiology*
;
Male
;
Child
;
Female
;
Singapore/epidemiology*
;
Anxiety/etiology*
;
Prospective Studies
;
Adolescent
;
Hospitalization
;
SARS-CoV-2
;
Adult
;
Child, Preschool
;
Pandemics
;
Parents/psychology*
;
Caregivers/psychology*
;
Family/psychology*
;
Depression
;
Patient Isolation/psychology*
;
Surveys and Questionnaires
7.Acupuncture combined with bamboo-based medicinal moxibustion for chronic insomnia complicated with mild depressive state: a randomized controlled trial.
Hongying LI ; Hongxuan WU ; Jin CUI
Chinese Acupuncture & Moxibustion 2025;45(1):3-9
OBJECTIVE:
To observe the clinical efficacy of acupuncture combined with bamboo-based medicinal moxibustion in the treatment of chronic insomnia complicated with mild depressive state.
METHODS:
A total of 60 patients with chronic insomnia complicated with mild depressive state were randomly divided into an observation group and a control group, 30 cases in each group. The control group was treated with acupuncture at bilateral Zhaohai (KI6), Shenmen (HT7), Sanyinjiao (SP6), Anmian (Extra) and Sishencong (EX-HN1), Baihui (GV20), etc. The observation group was treated with bamboo-based medicinal moxibustion based on the treatment in the control group, on the abdomen,Shenque (CV8), Guanyuan (CV4), Zhongwan (CV12) and bilateral Tianshu (ST25) were selected , on the back, the acupoints of governer vessel from Dazhui (GV14) to Yaoshu (GV2) were selected. Both groups were treated once every other day, 3 times a week for 4 weeks. The Pittsburgh sleep quality index (PSQI) score, Hamilton depression scale-17 (HAMD-17) score, insomnia severity index (ISI) score, fatigue assessment instrument (FAI) score before and after treatment and after 2 weeks of treatment completion (follow-up) were observed in the two groups, and the serum level of γ-aminobutyric acid (GABA) before and after treatment was detected in the two groups, and the clinical efficacy and safety were evaluated.
RESULTS:
After treatment and in the follow-up, the sub-item scores and total scores of PSQI in both groups were reduced compared with those before treatment (P<0.001); except for the score of daytime dysfunction in the follow-up, the scores of sleep quality, sleep duration, daytime dysfunction, and total scores of PSQI in the observation group were lower than those in the control group (P<0.05). After treatment and in the follow-up, the HAMD-17, ISI and FAI scores in both groups were reduced compared with those before treatment (P<0.001); the scores in the observation group were lower than those in the control group (P<0.05). After treatment,the serum levels of GABA in both groups were increased compared with those before treatment (P<0.05); the level in the observation group was higher than that in the control group (P<0.05). The total effective rate of treating chronic insomnia in the observation group was 96.7% (29/30), which was higher than 80.0% (24/30) in the control group (P<0.05); and the total effective rate of improving mild depressive state was 93.3% (28/30), which was higher than 66.7% (20/30) in the control group (P<0.001). During the treatment period, no serious adverse reactions occurred in both groups.
CONCLUSION
Acupuncture combined with bamboo-based medicinal moxibustion has definite efficacy in the treatment of chronic insomnia complicated with mild depressive state, and has synergistic efficacy in improving sleep quality, sleep duration, daytime dysfunction and depressive state, its action mechanism may be related to the increase of serum level of GABA.
Humans
;
Moxibustion
;
Sleep Initiation and Maintenance Disorders/therapy*
;
Male
;
Female
;
Middle Aged
;
Adult
;
Depression/therapy*
;
Acupuncture Therapy
;
Combined Modality Therapy
;
Treatment Outcome
;
Aged
;
Young Adult
;
Acupuncture Points
8.FU Wenbin's experience in treatment of post-stroke depression with holistic therapy of acupuncture and moxibusiton for Shugan Tiaoshen.
Yawen LI ; Bingxin WU ; Xiaochai GU ; Wenbin FU
Chinese Acupuncture & Moxibustion 2025;45(4):510-515
This paper introduces FU Wenbin's clinical experience in treatment of post-stroke depression with holistic therapy of acupuncture and moxibusiton for Shugan Tiaoshen (soothing the liver and regulating the mind). In pathogenesis, post-stroke depression is associated with the loss of the mind control and the failure of the liver in maintaining the free flow of qi. In treating principle, soothing the liver qi and regulating the mind are equally important, and the holistic regulation is applicable with the combination of multiple therapies. During treatment, the four-gate points are stimulated at first to promote liver qi flowing, the acupoints of the conception vessel and the governor vessel (e.g. Zhongwan [CV12], Guanyuan [CV4], Baihui [GV20], Yintang [GV24+]) are combined to regulate the mind and regain the consciousness. The conditions of illness are differentiated in terms of excess and deficiency, and the point prescription is modified accordingly. Refined moxibustion is applied specially at Fengchi (GB20), Fengfu (GV16) and Wangu (GB12) to warm meridians, strengthen yang and nourish the mind. In the last step of treatment, shallow needling techniques, such as the pricking and bloodletting, intradermal needling and auricular acupuncture, are used to consolidate the curative effect.
Humans
;
Acupuncture Therapy
;
Depression/etiology*
;
Stroke/psychology*
;
Female
;
Male
;
Middle Aged
;
Acupuncture Points
;
Moxibustion
;
Aged
;
Adult
9.Acupuncture and moxibustion combined with umbilical therapy for 30 cases of anxiety and depression in patients with neurogenic bladder after spinal cord injury.
Dongli WANG ; Xueqian WANG ; Rui WANG ; Youzhi HAO ; Weiwei QIAO ; Chao LI ; Yinping ZUO
Chinese Acupuncture & Moxibustion 2025;45(7):923-926
OBJECTIVE:
To observe the clinical effect of acupuncture and moxibustion combined with umbilical therapy on anxiety and depression in patients with neurogenic bladder (NB) after spinal cord injury (SCI).
METHODS:
Thirty cases of NB after SCI with anxiety and depression were selected and treated with acupuncture and moxibustion combined with umbilical therapy. Acupuncture was applied at Baihui (GV20), Yintang (GV24+), Sanyinjiao (SP6), Shenmen (HT7), Hegu (LI4), Taichong (LR3), once a day, continuous treatment for 4 weeks. Ginger moxibustion was applied at the bladder meridian of foot taiyang and governor vessel, once a day, continuous treatment for 4 weeks. In treatment of umbilical therapy, Chaihu (Radix Bupleuri), Yujin (Radix Curcumae), Rougui (Cortex Cinnamomi) were ground and mixed with the same amount of honey, put into the application, and the application was placed on the navel after filling the navel with fine salt, once a day for 4 weeks. Hamilton anxiety scale (HAMA) score, Hamilton depression scale (HAMD) score, urodynamic indexes (maximum urinary flow rate [Qmax], maximum detrusor pressure [Pdet-max], residual urine volume [RUV]), neurogenic bladder symptom score (NBSS), urinary symptom distress scale (USDS) score were compared before and after treatment, and the clinical efficacy was evaluated.
RESULTS:
After treatment, the scores of HAMA, HAMD, NBSS, USDS and RUVwere lower than those before treatment (P<0.05), and Qmax and Pdet-max were higher than those before treatment (P<0.05). The total effective rate was 93.3 (28/30).
CONCLUSION
Acupuncture and moxibustion combined with umbilical therapy can effectively relieve anxiety and depression symptoms, improve urination disorders in patients with NB after SCI.
Humans
;
Moxibustion
;
Male
;
Female
;
Adult
;
Middle Aged
;
Acupuncture Therapy
;
Spinal Cord Injuries/psychology*
;
Depression/etiology*
;
Anxiety/etiology*
;
Urinary Bladder, Neurogenic/etiology*
;
Young Adult
;
Aged
;
Combined Modality Therapy
;
Acupuncture Points
10.Heat-sensitive moxibustion robot for improving depressive state in methamphetamine addicts during withdrawal period: a randomized controlled trial.
Yuexia JIANG ; Haiyan LI ; Wei HE ; Jing ZHOU ; Chunliang ZOU ; Dingyi XIE ; Rixin CHEN
Chinese Acupuncture & Moxibustion 2025;45(8):1061-1067
OBJECTIVE:
To observe the clinical efficacy of heat-sensitive moxibustion robot for improving the depressive state of methamphetamine addicts during withdrawal period.
METHODS:
A total of 60 patients with methamphetamine addiction accompanied with depressive state were randomly divided into an observation group (40 cases, 4 cases dropped out) and a control group (20 cases, 2 cases dropped out). The control group received routine health education and addiction treatment in compulsory isolation drug rehabilitation center. On the basis of the treatment in the control group, in the observation group, the heat-sensitive moxibustion robot was used to locate sensitive points at the Shenque (CV8) and Danzhong (CV17), and dual-point sparrow-pecking moxibustion was delivered for 60 min per session. The moxibustion therapy was performed 4 times in the 1st week, 3 times in the 2nd and 3rd weeks respectively, and 2 times in the 4th week, for 12 times totally. The scores of Hamilton depression scale (HAMD), self-rating depression scale (SDS), visual analogue scale (VAS) for drug craving, Hamilton anxiety scale (HAMA), self-rating anxiety scale (SAS), and Pittsburgh sleep quality index (PSQI) were observed before treatment, at the end of the 2nd and 4th weeks of treatment, and 4 weeks after the treatment completion (follow-up) in the two groups.
RESULTS:
At each time point after treatment, in the observation group, the HAMD, VAS, HAMA and PSQI scores were decreased compared with those before treatment (P<0.01, P<0.001); at the end of the 4th week of treatment and in follow-up, the SDS and SAS scores were decreased compared with those before treatment (P<0.001, P<0.01). Compared before treatment, there were no significant differences in the above scores at each time point after treatment in the control group (P>0.05). In the observation group, at each time point after treatment, the HAMD and VAS scores were lower than those in the control group (P<0.01, P<0.001, P<0.05); at the end of the 4th week of treatment and in follow-up, the SDS and HAMA scores were lower than those in the control group (P<0.05, P<0.001); at the end of the 4th week of treatment, the PSQI score was lower than that in the control group (P<0.01).
CONCLUSION
Heat-sensitive moxibustion robot effectively improves depression, anxiety and sleep quality, and reduces drug craving in methamphetamine addicts during withdrawal period.
Humans
;
Moxibustion/methods*
;
Male
;
Adult
;
Female
;
Methamphetamine/adverse effects*
;
Depression/therapy*
;
Middle Aged
;
Robotics
;
Young Adult
;
Amphetamine-Related Disorders/psychology*
;
Acupuncture Points
;
Substance Withdrawal Syndrome/psychology*


Result Analysis
Print
Save
E-mail